Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Impaired protein degradation in FTLD and related disorders.

Götzl JK, Lang CM, Haass C, Capell A.

Ageing Res Rev. 2016 May 7. pii: S1568-1637(16)30065-4. doi: 10.1016/j.arr.2016.04.008. [Epub ahead of print] Review.

PMID:
27166223
2.

Lysosomal Acid Phosphatase Biosynthesis and Dysfunction: A Mini Review Focused on Lysosomal Enzyme Dysfunction in Brain.

Ashtari N, Jiao X, Rahimi-Balaei M, Amiri S, Mehr SE, Yeganeh B, Marzban H.

Curr Mol Med. 2016;16(5):439-46. Review.

PMID:
27132795
3.

Lysosomal cathepsins and their regulation in aging and neurodegeneration.

Stoka V, Turk V, Turk B.

Ageing Res Rev. 2016 Apr 26. pii: S1568-1637(16)30067-8. doi: 10.1016/j.arr.2016.04.010. [Epub ahead of print] Review.

4.

Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.

Geraets RD, Koh Sy, Hastings ML, Kielian T, Pearce DA, Weimer JM.

Orphanet J Rare Dis. 2016 Apr 16;11:40. doi: 10.1186/s13023-016-0414-2. Review.

5.

Gene Therapy for Rare Central Nervous System Diseases Comes to Age.

Aubourg P.

Endocr Dev. 2016;30:141-6. doi: 10.1159/000439339. Epub 2015 Dec 10. Review.

PMID:
26684481
6.

Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.

Chen X, Barclay JW, Burgoyne RD, Morgan A.

Chem Cent J. 2015 Nov 26;9:65. doi: 10.1186/s13065-015-0143-y. eCollection 2015. Review.

7.

From rare to common and back again: 60years of lysosomal dysfunction.

Coutinho MF, Alves S.

Mol Genet Metab. 2016 Feb;117(2):53-65. doi: 10.1016/j.ymgme.2015.08.008. Epub 2015 Aug 18. Review.

PMID:
26422115
8.

Lacritin and other autophagy associated proteins in ocular surface health.

Karnati R, Talla V, Peterson K, Laurie GW.

Exp Eye Res. 2016 Mar;144:4-13. doi: 10.1016/j.exer.2015.08.015. Epub 2015 Aug 25. Review.

PMID:
26318608
9.

Using Stem Cells to Model Diseases of the Outer Retina.

Yvon C, Ramsden CM, Lane A, Powner MB, da Cruz L, Coffey PJ, Carr AJ.

Comput Struct Biotechnol J. 2015 May 6;13:382-9. doi: 10.1016/j.csbj.2015.05.001. eCollection 2015. Review.

10.

The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs).

Palmer DN.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2287-91. doi: 10.1016/j.bbadis.2015.06.014. Epub 2015 Jun 17. Review.

PMID:
26093153
11.

Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network.

Palmer DN, Neverman NJ, Chen JZ, Chang CT, Houweling PJ, Barry LA, Tammen I, Hughes SM, Mitchell NL.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2279-86. doi: 10.1016/j.bbadis.2015.06.013. Epub 2015 Jun 12. Review.

PMID:
26073432
12.

Progressive Myoclonus Epilepsies.

Kälviäinen R.

Semin Neurol. 2015 Jun;35(3):293-9. doi: 10.1055/s-0035-1552620. Epub 2015 Jun 10. Review.

PMID:
26060909
13.

Genetics of the neuronal ceroid lipofuscinoses (Batten disease).

Mole SE, Cotman SL.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2237-41. doi: 10.1016/j.bbadis.2015.05.011. Epub 2015 May 27. Review.

PMID:
26026925
14.

Towards a new understanding of NCL pathogenesis.

Cooper JD, Tarczyluk MA, Nelvagal HR.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2256-61. doi: 10.1016/j.bbadis.2015.05.014. Epub 2015 May 28. Review.

PMID:
26026924
15.

Human NCL Neuropathology.

Radke J, Stenzel W, Goebel HH.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2262-6. doi: 10.1016/j.bbadis.2015.05.007. Epub 2015 May 16. Review.

PMID:
25989315
16.

The neuronal ceroid lipofuscinoses program: A translational research experience in Argentina.

Kohan R, Pesaola F, Guelbert N, Pons P, Oller-Ramírez AM, Rautenberg G, Becerra A, Sims K, Xin W, Cismondi IA, Noher de Halac I.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2301-11. doi: 10.1016/j.bbadis.2015.05.003. Epub 2015 May 11. Review.

PMID:
25976102
17.

Cell biology of the NCL proteins: What they do and don't do.

Cárcel-Trullols J, Kovács AD, Pearce DA.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2242-55. doi: 10.1016/j.bbadis.2015.04.027. Epub 2015 May 8. Review.

PMID:
25962910
18.

Experimental therapies in the neuronal ceroid lipofuscinoses.

Neverman NJ, Best HL, Hofmann SL, Hughes SM.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2292-300. doi: 10.1016/j.bbadis.2015.04.026. Epub 2015 May 6. Review.

PMID:
25957554
19.

The neuronal ceroid lipofuscinoses: Opportunities from model systems.

Faller KM, Gutierrez-Quintana R, Mohammed A, Rahim AA, Tuxworth RI, Wager K, Bond M.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2267-78. doi: 10.1016/j.bbadis.2015.04.022. Epub 2015 Apr 29. Review.

PMID:
25937302
20.

Future perspectives: Moving towards NCL treatments.

Cotman SL, Mole SE, Kohan R.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2336-8. doi: 10.1016/j.bbadis.2015.04.001. Epub 2015 Apr 7. Review.

PMID:
25857620
Items per page

Supplemental Content

Loading ...
Write to the Help Desk